Evaluation of the Aspergillus Western Blot IgG Kit for Diagnosis of Chronic Aspergillosis
A Oliva,P Flori,C Hennequin,J-C Dubus,M Reynaud-Gaubert,D Charpin,J M Vergnon,P Gay,A Colly,R Piarroux,H Pelloux,S Ranque,A. Oliva,P. Flori,C. Hennequin,J.-C. Dubus,M. Reynaud-Gaubert,D. Charpin,J. M. Vergnon,P. Gay,A. Colly,R. Piarroux,H. Pelloux,S. Ranque
DOI: https://doi.org/10.1128/jcm.02690-14
2015-01-01
Journal of Clinical Microbiology
Abstract:ABSTRACT Immunoprecipitin detection (IPD) is the current reference confirmatory technique for anti- Aspergillus antibody detection; however, the lack of standardization is a critical drawback of this assay. In this study, we evaluated the performance of the Aspergillus Western blot ( Asp -WB) IgG kit (LDBio Diagnostics, Lyon, France), a recently commercialized immunoblot assay for the diagnosis of various clinical presentations of chronic aspergillosis. Three hundred eight serum samples from 158 patients with aspergillosis sensu lato (s.l.) were analyzed. More specifically, 267 serum samples were derived from patients with Aspergillus disease, including 89 cases of chronic pulmonary aspergillosis, 10 of aspergilloma, and 32 of allergic bronchopulmonary aspergillosis, while 41 samples were from patients with Aspergillus colonization, including 15 cystic fibrosis (CF) and 12 non-CF patients. For blood donor controls, the Asp -WB specificity was 94%, while the kit displayed a sensitivity for the aspergillosis s.l. diagnosis of 88.6%, with a diagnostic odds ratio (DOR) of 119 (95% confidence interval [CI], 57 to 251). The DOR values were 185.22 (95% CI,78.79 to 435.45) and 43.74 (95% CI, 15.65 to 122.20) for the diagnosis of Aspergillus disease and Aspergillus colonization, respectively. Among the patients, the sensitivities of the Asp -WB in the diagnosis of Aspergillus colonization were 100% and 41.7% in CF and non-CF patients, respectively. The Asp -WB yielded fewer false-negative results than did IPD. In conclusion, the Asp -WB kit performed well for the diagnosis of various clinical presentations of aspergillosis in nonimmunocompromised patients, with an enhanced standardization and a higher sensitivity than with IPD, which is the current reference method.
microbiology